A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions.
All pharmaceutical companies are required to assess pharmacokinetic drug-drug interactions (DDIs) of new chemical entities (NCEs) and mathematical prediction helps to select the best NCE candidate with regard to adverse effects resulting from a DDI before any costly clinical studies. Most current mo...
Saved in:
| Main Authors: | Mohammed H Cherkaoui-Rbati, Stuart W Paine, Peter Littlewood, Cyril Rauch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183794&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes.
by: Urs Duthaler, et al.
Published: (2021-03-01) -
Drug Transporters and Metabolizing Enzymes in Antimicrobial Drug Pharmacokinetics: Mechanisms, Drug–Drug Interactions, and Clinical Implications
by: Kaili Lin, et al.
Published: (2025-06-01) -
Editorial on Special Issue “Pharmacokinetics, Pharmacodynamics, and Drug Interactions”
by: Zhu Zhou
Published: (2025-02-01) -
The Effect of Drug–Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review
by: Sang Y, et al.
Published: (2025-06-01) -
Evaluation of Luteolin Nanosuspensions on Pharmacokinetics of Atorvastatin: Drug-Drug Interactions Using Rat Models
by: Liang Y, et al.
Published: (2025-02-01)